A Safety Study of SGN-CD47M in Patients With Solid Tumors
Status:
Terminated
Trial end date:
2020-09-14
Target enrollment:
Participant gender:
Summary
This trial will study SGN-CD47M to find out whether it is an effective treatment for
different types of solid tumors and what side effects (unwanted effects) may occur. The study
will have two parts. Part A of the study will find out how much SGN-CD47M should be given for
treatment and how often. Part B of the study will use the dose found in Part A and look at
how safe and effective the treatment is.